Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
Cyclin-dependent kinase 9 (CDK9) phosphorylates RNA polymerase II to promote productive transcription elongation. Here we show that short-term CDK9 inhibition affects the splicing of thousands of mRNAs. CDK9 inhibition impairs global splicing and there is no evidence for a coordinated response betwe...
Main Authors: | Hu, Q, Poulose, N, Girmay, S, Helevä, A, Doultsinos, D, Gondane, A, Steele, RE, Liu, X, Loda, M, Liu, S, Tang, D, Mills, IG, Itkonen, HM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Taylor and Francis
2021
|
Similar Items
-
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition
by: Gondane, A, et al.
Published: (2022) -
CDK9 inhibition activates innate immune response through viral mimicry
by: Yalala, S, et al.
Published: (2024) -
Inhibition of O-GlcNAc transferase renders prostate cancer cells dependent on CDK9
by: Itkonen, HM, et al.
Published: (2020) -
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage
by: Aishwarya Gondane, et al.
Published: (2022-02-01) -
CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation
by: Itkonen, H, et al.
Published: (2019)